A new radiopaque embolizing agent for the treatment of endoleaks after endovascular repair: Influence of contrast agent on chitosan thermogel properties

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 101 B, Issue 1, 2013, Pages 153-161

  Coutu, Jean Michel ^a,b   Fatimi, Ahmed ^a,b   Berrahmoune, Saoussen ^a,b   Soulez, Gilles ^c   Lerouge, Sophie ^a,b,c  

^a ÉCOLE DE TECHNOLOGIE SUPÉRIEURE   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^c NOTRE DAME HOSPITAL   (Canada)

Author keywords

abdominal aortic aneurysm; chitosan thermogels; embolization; radiopacity

Indexed keywords

ABDOMINAL AORTIC ANEURYSMS; BODY TEMPERATURE; CONTRAST AGENT; CYTOTOXIC COMPOUNDS; DEGREE OF DEACETYLATION; EMBOLIZATION; ENDOLEAKS; ENDOVASCULAR; ENDOVASCULAR REPAIR; GELATION KINETICS; GLYCEROPHOSPHATE; IN-VITRO; OSMOLALITY; RADIOPACITY; RAPID RELEASE; SALINE SOLUTIONS; THERMOGELLING; THERMOGELS;

ACETYLATION; CHITOSAN; CYTOTOXICITY; GELATION; MECHANICAL PROPERTIES; PHOSPHOLIPIDS;

HYDROGELS;

CHITOSAN; CHITOSAN BETA GLYCEROPHOSPHATE; CONTRAST MEDIUM; GLYCEROPHOSPHATE; IODIXANOL; IOPAMIDOL; MEGLUMINE IOTALAMATE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ARTICLE; ARTIFICIAL EMBOLISM; BODY TEMPERATURE; COMPRESSION; CONTROLLED STUDY; CYTOTOXICITY; DEACETYLATION; ENDOLEAK; ENDOVASCULAR ANEURYSM REPAIR; FEASIBILITY STUDY; FLOW KINETICS; GELATION; HYDROGEL; IN VITRO STUDY; KINETICS; MECHANICS; OSMOLALITY; RADIOLOGICAL PARAMETERS; RADIOPACITY; VISCOSITY; X RAY;

ANEURYSM; ANIMALS; CELL LINE; CELL SURVIVAL; CHITOSAN; CONTRAST MEDIA; EMBOLIZATION, THERAPEUTIC; GELS; MICE; OSMOLAR CONCENTRATION; RHEOLOGY;

EID: 84871363551     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.32828     Document Type: Article

References (45)

1. Seron A, Moine L, Laurent A, Wassef M, Guiffant G, Flaud P, Labarre D,. An embolic gelling solution based on acrylic copolymers in ethanol for the treatment of arteriovenous malformations. Biomaterials 2009; 30: 3436-3443.
2. The n-BCA Trial Investigators. N-Butyl cyanoacrylate embolization of cerebral arteriovenous malformations: Results of a prospective, randomized, multi-center trial. Am J Neuroradiol 2002; 23: 748-755.
3. Becker TA, Preul MC, Bichard WD, Kipke DR, McDougall CG,. Calcium alginate gel as a biocompatible material for endovascular arteriovenous malformation embolization: Six-month results in an animal model. Neurosurgery 2005; 56: 793-801.
4. Loh Y, Duckwiler GR,. A prospective, multicenter, randomized trial of the Onyx liquid embolic system and N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations. J Neurosurg 2010; 113: 733-741.
5. Bosman WMPF, Vlot J, van der Steenhoven TJ, van den Berg O, Hamming JF, de Vries AC, Brom HLF, Jacobs MJ,. Aortic customize: An in vivo feasibility study of a percutaneous technique for the repair of aortic aneurysms using injectable elastomer. Eur J Vasc Endovasc Surg 2010; 40: 65-70.
6. Martin ML, Dolmatch BL, Fry PD, Machan LS,. Treatment of type II endoleaks with Onyx. J Vasc Intervent Radiol 2001; 12: 629-632. (Pubitemid 32423076)
7. Dompmartin A, Blaizot X, Theron J, Hammer F, Chene Y, Labbe D, Barrellier MT, Gaillard C, Leroyer R, Chedru V, Ollivier C, Vikkula M, Boon LM,. Radio-opaque ethylcellulose-ethanol is a safe and efficient sclerosing agent for venous malformations. Eur Radiol 2011; 21: 2647-2656.
8. Barnett BP, Gailloud P,. Assessment of embogel-A selectively dissolvable radiopaque hydrogel for embolic applications. J Vasc Intervent Radiol 2011; 22: 203-211.
9. Sarac TP, Gibbons C, Vargas L, Liu J, Srivastava S, Bena J, Mastracci T, Kashyap VS, Clair D,. Long-term follow-up of type II endoleak embolization reveals the need for close surveillance. J Vasc Surg 2012; 55: 33-40.
10. Mehta M, Sternbach Y, Taggert JB, Kreienberg PB, Roddy SP, Paty PS, Ozsvath KJ, Darling RC III,. Long-term outcomes of secondary procedures after endovascular aneurysm repair. J Endovasc Surg 2010; 52: 1442-1449.
11. Ronsivalle S, Faresin F, Franz F, Rettore C, Zanchetta M, Olivieri A,. Aneurysm sac "thrombization" and stabilization in EVAR: A technique to reduce the risk of type II endoleak. J Endovasc Ther 2010; 17: 517-524.
12. Zanchetta M, Faresin F, Pedon L, Ronsivalle S,. Intraoperative intrasac thrombin injection to prevent type II endoleak after endovascular abdominal aortic aneurysm repair. J Endovasc Ther 2007; 14: 176-183. (Pubitemid 46776115)
13. Nevala T, Biancari F, Manninen H, Aho PS, Matsi P, Makinen K, Roth WD, Ylonen K, Lepantalo M, Perala J,. Type II endoleak after endovascular repair of abdominal aortic aneurysm: Effectiveness of embolization. Cardiovasc Intervent Radiol 2010; 33: 278-284.
14. Baum RA, Carpenter JP, Golden MA, Velazquez OC, Clark TW, Stavropoulos SW, Cope C, Fairman RM,. Treatment of type 2 endoleaks after endovascular repair of abdominal aortic aneurysms: Comparison of transarterial and translumbar techniques. J Vasc Surg 2002; 35: 23-29. (Pubitemid 44725764)
15. Bakar B, Oruckaptan HH, Hazer BD, Saatci I, Atilla P, Kilic K, Muftuoglu SF,. Evaluation of the toxicity of onyx compared with n-butyl 2-cyanoacrylate in the subarachnoid space of a rabbit model: An experimental research. Neuroradiology 2010; 52: 125-134.
16. Conrad MF, Adams AB, Guest JM, Paruchuri V, Brewster DC, LaMuraglia GM, Cambria RP,. Secondary intervention after endovascular abdominal aortic aneurysm repair. Ann Surg 2009; 250: 383-389.
17. Ling AJ, Pathak R, Garbowski M, Nadkarni S,. Treatment of a large type II endoleak via extraperitoneal dissection and embolization of a collateral vessel using ethylene vinyl alcohol copolymer (Onyx). J Vasc Intervent Radiol 2007; 18: 659-662. (Pubitemid 46661168)
18. Grisafi JL, Boiteau G, Detschelt E, Potts J, Kiproff P, Muluk SC,. Endoluminal treatment of type IA endoleak with Onyx. J Vasc Surg 2010; 52: 1346-1349.
19. Natarajan SK, Born D, Ghodke B, Britz GW, Sekhar LN,. Histopathological changes in brain arteriovenous malformations after embolization using Onyx or N-butyl cyanoacrylate. J Neurosurg 2009; 111: 105-113.
20. Fatimi A, Chabrot P, Berrahoume S, Coutu JM, Soulez G, Lerouge S,. A new injectable radiopaque chitosan-based sclerosing embolizing hydrogel for endovascular therapies. Acta Biomater 2012; 8: 2712-2721.
21. Chenite A, Buschmann M, Wang D, Chaput C, Kandani N,. Rheological characterisation of thermogelling chitosan/glycerol-phosphate solutions. Carbohydr Polym 2001; 46: 39-47. (Pubitemid 32487087)
22. Cho J, Heuzey M-C,. Dynamic scaling for gelation of a thermosensitive chitosan-β-glycerophosphate hydrogel. Colloid Polym Sci 2008; 286: 427-434.
23. Rinaudo M,. Properties and degradation of selected polysaccharides: Hyaluronan and chitosan. Corros Eng Sci Technol 2007; 42: 324-334.
24. Rinaudo M,. Main properties and current applications of some polysaccharides as biomaterials. Polym Int 2008; 57: 397-430. (Pubitemid 351283101)
25. Ahmadi R, de Bruijn JD,. Biocompatibility and gelation of chitosan-glycerol phosphate hydrogels. J Biomed Mater Res Part A 2008; 86A: 824-832.
26. Ruel-Gariépy E, Chenite A, Chaput C, Guirguis S, Leroux JC,. Characterization of thermosensitive chitosan gels for the sustained delivery of drugs. Int J Pharm 2000; 203: 89-98. (Pubitemid 30627629)
27. Cho J, Heuzey M-C, Bégin A, Carreau PJ,. Chitosan and glycerophosphate concentration dependence of solution behaviour and gel point using small amplitude oscillatory rheometry. Food Hydrocolloids 2006; 20: 936-945. (Pubitemid 44209059)
28. Cho J, Heuzey M-C, Bégin A, Carreau PJ,. Viscoelastic properties of chitosan solutions: Effect of concentration and ionic strength. J Food Eng 2006; 74: 500-515. (Pubitemid 43190120)
29. Cox WP, Merz EH,. Correlation of dynamic and steady flow viscosities. J Polym Sci 1958; 28: 619-622.
30. Fatimi A, Coutu JM, Cloutier G, Lerouge S,. Rheological studies of an injectable radiopaque hydrogel for embolization of abdominal aortic aneurysms. Adv Mater Res 2012; 409: 129-135.
31. Winter HH, Chambon F,. Analysis of linear viscoelasticity of a crosslinking polymer at the gel point. J Rheol 1986; 30: 367-382. (Pubitemid 16535398)
32. Coviello T, Alhaique F, Parisi C, Matricardi P, Bocchinfuso G, Grassi M,. A new polysaccharidic gel matrix for drug delivery: Preparation and mechanical properties. J Control Release 2005; 102: 643-656. (Pubitemid 40170207)
33. Jones DS, Woolfson AD, Djokic J, Coulter WA,. Development and mechanical characterization of bioadhesive semi-solid, polymeric systems containing tetracycline for the treatment of periodontal diseases. Pharm Res 1996; 13: 1734-1738. (Pubitemid 26426902)
34. Sahani DV, Soulez G, Chen K-M, Lepanto L, Xu J-R, Nelson RC, Grazioli L, Vanzulli A, Heiken JP, Study tIotI. A Comparison of the efficacy and safety of Iopamidol-370 and Iodixanol-320 in patients undergoing multidetector-row computed tomography. Investig Radiol 2007; 42: 856-861. (Pubitemid 350126568)
35. Kuo CK, Ma PX,. Ionically crosslinked alginate hydrogels as scaffolds for tissue engineering: Part 1. Structure, gelation rate and mechanical properties. Biomaterials 2001; 22: 511-521. (Pubitemid 32015873)
36. Wang X, Li X,. Computational simulation of aortic aneurysm using FSI method: Influence of blood viscosity on aneurismal dynamic behaviors. Comput Biol Med 2011; 41: 812-821.
37. Lavertu M, Filion D, Buschmann MD,. Heat-induced transfer of protons from chitosan to glycerol phosphate produces chitosan precipitation and gelation. Biomacromolecules 2008; 9: 640-650. (Pubitemid 351298489)
38. Filion D, Lavertu M, Buschmann MD,. Ionization and solubility of chitosan solutions related to thermosensitive chitosan/glycerol-phosphate Systems. Biomacromolecules 2007; 8: 3224-3234. (Pubitemid 350011646)
39. Ganji F, Abdekhodaie MJ, Ramazani SA,. Gelation time and degradation rate of chitosan-based injectable hydrogel. J Sol-Gel Sci Technol 2007; 42: 47-53.
40. Stammen JA, Williams S, Ku DN, Guldberg RE,. Mechanical properties of a novel PVA hydrogel in shear and unconfined compression. Biomaterials 2001; 22: 799-806. (Pubitemid 32143794)
41. Ho E, Lowman A, Marcolongo M,. Synthesis and characterization of an injectable hydrogel with tunable mechanical properties for soft tissue repair. Biomacromolecules 2006; 7: 3223-3228. (Pubitemid 46039983)
42. Berger J, Reist M, Mayer JM, Felt O, Peppas NA, Gurny R,. Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications. Eur J Pharm Biopharm 2004; 57: 19-34. (Pubitemid 38058801)
43. Khare AR, Peppas NA, Massimo G, Colombo P,. Measurement of the swelling force in ionic polymeric networks I. Effect of pH and ionic content. J Control Release 1992; 22: 239-244.
44. Coma V,. Système gélifiant de chitosane. In:, Crini G, Badot PM, Guibal E, editors. Chitine et chitosane: Du biopolymère à l'application. Besançon: Presse Universitaire de Franch-Compté; 2009. pp 145-167.
45. Schick CS, Haller C,. Comparative cytotoxicity of ionic and non-ionic radiocontrast agents on MDCK cell monolayers in vitro. Nephrol Dial Transplant 1999; 14: 342-347. (Pubitemid 29062788)